Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants

Hung Chih Lin, Bai Horng Su, An Chyi Chen, Tsung Wen Lin, Chang Hai Tsai, Tsu Fuh Yeh, William Oh

Research output: Contribution to journalArticle

493 Citations (Scopus)

Abstract

Objective. We evaluated the efficacy of probiotics in reducing the incidence and severity of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants. Patients and Methods. A prospective, masked, randomized control trial was conducted to evaluate the beneficial effects of probiotics in reducing the incidence and severity of NEC among VLBW (<1500 g) infants. VLBW infants who started to fed enterally and survived beyond the seventh day after birth were eligible for the trial. They were randomized into 2 groups after parental informed consents were obtained. The infants in the study group were fed with Infloran (Lactobacillus acidophilus and Bifidobacterium infantis) with breast milk twice daily until discharged. Infants in the control group were fed with breast milk alone. The clinicians caring for the infants were blinded to the group assignment. The primary outcome was death or NEC (≥ stage 2). Results. Three hundred sixty-seven infants were enrolled: 180 in the study group and 187 in the control group. The demographic and clinical variables were similar in both groups. The incidence of death or NEC (≥ stage 2) was significantly lower in the study group (9 of 180 vs 24 of 187). The incidence of NEC (≥ stage 2) was also significantly lower in the study when compared with the control group (2 of 180 vs 10 of 187). There were 6 cases of severe NEC (Bell stage 3) in the control group and none in the study group. None of the positive blood culture grew Lactobacillus or Bifidobacterium species. Conclusion. Infloran as probiotics fed enterally with breast milk reduces the incidence and severity of NEC in VLBW infants.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalPediatrics
Volume115
Issue number1
DOIs
Publication statusPublished - Jan 1 2005
Externally publishedYes

Fingerprint

Necrotizing Enterocolitis
Very Low Birth Weight Infant
Probiotics
Incidence
Human Milk
Control Groups
Parental Consent
Lactobacillus acidophilus
Bifidobacterium
Lactobacillus
Informed Consent
Demography
Parturition

Keywords

  • Mortality
  • Necrotizing enterocolitis
  • Probiotics
  • Sepsis
  • Very low birth weight infants

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. / Lin, Hung Chih; Su, Bai Horng; Chen, An Chyi; Lin, Tsung Wen; Tsai, Chang Hai; Yeh, Tsu Fuh; Oh, William.

In: Pediatrics, Vol. 115, No. 1, 01.01.2005, p. 1-4.

Research output: Contribution to journalArticle

Lin, Hung Chih ; Su, Bai Horng ; Chen, An Chyi ; Lin, Tsung Wen ; Tsai, Chang Hai ; Yeh, Tsu Fuh ; Oh, William. / Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. In: Pediatrics. 2005 ; Vol. 115, No. 1. pp. 1-4.
@article{833cb8aab9fd416eb9248dd43c18fc50,
title = "Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants",
abstract = "Objective. We evaluated the efficacy of probiotics in reducing the incidence and severity of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants. Patients and Methods. A prospective, masked, randomized control trial was conducted to evaluate the beneficial effects of probiotics in reducing the incidence and severity of NEC among VLBW (<1500 g) infants. VLBW infants who started to fed enterally and survived beyond the seventh day after birth were eligible for the trial. They were randomized into 2 groups after parental informed consents were obtained. The infants in the study group were fed with Infloran (Lactobacillus acidophilus and Bifidobacterium infantis) with breast milk twice daily until discharged. Infants in the control group were fed with breast milk alone. The clinicians caring for the infants were blinded to the group assignment. The primary outcome was death or NEC (≥ stage 2). Results. Three hundred sixty-seven infants were enrolled: 180 in the study group and 187 in the control group. The demographic and clinical variables were similar in both groups. The incidence of death or NEC (≥ stage 2) was significantly lower in the study group (9 of 180 vs 24 of 187). The incidence of NEC (≥ stage 2) was also significantly lower in the study when compared with the control group (2 of 180 vs 10 of 187). There were 6 cases of severe NEC (Bell stage 3) in the control group and none in the study group. None of the positive blood culture grew Lactobacillus or Bifidobacterium species. Conclusion. Infloran as probiotics fed enterally with breast milk reduces the incidence and severity of NEC in VLBW infants.",
keywords = "Mortality, Necrotizing enterocolitis, Probiotics, Sepsis, Very low birth weight infants",
author = "Lin, {Hung Chih} and Su, {Bai Horng} and Chen, {An Chyi} and Lin, {Tsung Wen} and Tsai, {Chang Hai} and Yeh, {Tsu Fuh} and William Oh",
year = "2005",
month = "1",
day = "1",
doi = "10.1542/peds.2004-1463",
language = "English",
volume = "115",
pages = "1--4",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants

AU - Lin, Hung Chih

AU - Su, Bai Horng

AU - Chen, An Chyi

AU - Lin, Tsung Wen

AU - Tsai, Chang Hai

AU - Yeh, Tsu Fuh

AU - Oh, William

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Objective. We evaluated the efficacy of probiotics in reducing the incidence and severity of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants. Patients and Methods. A prospective, masked, randomized control trial was conducted to evaluate the beneficial effects of probiotics in reducing the incidence and severity of NEC among VLBW (<1500 g) infants. VLBW infants who started to fed enterally and survived beyond the seventh day after birth were eligible for the trial. They were randomized into 2 groups after parental informed consents were obtained. The infants in the study group were fed with Infloran (Lactobacillus acidophilus and Bifidobacterium infantis) with breast milk twice daily until discharged. Infants in the control group were fed with breast milk alone. The clinicians caring for the infants were blinded to the group assignment. The primary outcome was death or NEC (≥ stage 2). Results. Three hundred sixty-seven infants were enrolled: 180 in the study group and 187 in the control group. The demographic and clinical variables were similar in both groups. The incidence of death or NEC (≥ stage 2) was significantly lower in the study group (9 of 180 vs 24 of 187). The incidence of NEC (≥ stage 2) was also significantly lower in the study when compared with the control group (2 of 180 vs 10 of 187). There were 6 cases of severe NEC (Bell stage 3) in the control group and none in the study group. None of the positive blood culture grew Lactobacillus or Bifidobacterium species. Conclusion. Infloran as probiotics fed enterally with breast milk reduces the incidence and severity of NEC in VLBW infants.

AB - Objective. We evaluated the efficacy of probiotics in reducing the incidence and severity of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants. Patients and Methods. A prospective, masked, randomized control trial was conducted to evaluate the beneficial effects of probiotics in reducing the incidence and severity of NEC among VLBW (<1500 g) infants. VLBW infants who started to fed enterally and survived beyond the seventh day after birth were eligible for the trial. They were randomized into 2 groups after parental informed consents were obtained. The infants in the study group were fed with Infloran (Lactobacillus acidophilus and Bifidobacterium infantis) with breast milk twice daily until discharged. Infants in the control group were fed with breast milk alone. The clinicians caring for the infants were blinded to the group assignment. The primary outcome was death or NEC (≥ stage 2). Results. Three hundred sixty-seven infants were enrolled: 180 in the study group and 187 in the control group. The demographic and clinical variables were similar in both groups. The incidence of death or NEC (≥ stage 2) was significantly lower in the study group (9 of 180 vs 24 of 187). The incidence of NEC (≥ stage 2) was also significantly lower in the study when compared with the control group (2 of 180 vs 10 of 187). There were 6 cases of severe NEC (Bell stage 3) in the control group and none in the study group. None of the positive blood culture grew Lactobacillus or Bifidobacterium species. Conclusion. Infloran as probiotics fed enterally with breast milk reduces the incidence and severity of NEC in VLBW infants.

KW - Mortality

KW - Necrotizing enterocolitis

KW - Probiotics

KW - Sepsis

KW - Very low birth weight infants

UR - http://www.scopus.com/inward/record.url?scp=16844361972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844361972&partnerID=8YFLogxK

U2 - 10.1542/peds.2004-1463

DO - 10.1542/peds.2004-1463

M3 - Article

C2 - 15629973

AN - SCOPUS:16844361972

VL - 115

SP - 1

EP - 4

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -